Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT00165256

Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast

Wide Excision Alone for DCIS-Grades 1 and 2

Status
Active Not Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
158 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if wide excision (surgical removal) alone is adequate treatment for small, grade 1 or 2 ductal carcinoma in situ (DCIS) of the breast.

Detailed description

* Patients with DCIS are usually treated with the combination of breast-conserving surgery and radiation therapy or breast-conserving surgery alone. The purpose of this study is to evaluate whether localized low- or intermediate-grade DCIS, diagnosed with modern mammography and careful pathologic evaluation, could be treated with wide excision alone (omission of radiation therapy) and result in acceptably low local recurrence rates. * Follow-up consists of physical examinations at least every 6 months by the surgeon or radiation oncologist. Mammograms of the affected breast will be obtained every 6 months for 5 years and then annually. Mammograms of the unaffected breast will be performed annually.

Conditions

Interventions

TypeNameDescription
OTHERObservationWide excision of DCIS and a minimum of 1cm histologically negative margin of breast tissue

Timeline

Start date
1995-05-01
Primary completion
2002-07-01
Completion
2027-12-01
First posted
2005-09-14
Last updated
2025-12-29

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00165256. Inclusion in this directory is not an endorsement.